Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620)

Cancer Letters

Volumn 131, Issue 1, 1998, Pages 55-64

  Kubens, Britta S ^a   Zänker, Kurt S ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

CD44; Cell migration; Hermes 1; Hyaluronic acid; SW480; SW620

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

CARCINOMA CELL; CELL MIGRATION; CELL SHAPE; COLON CARCINOMA; CONFERENCE PAPER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIGENS, CD44; CELL MOVEMENT; COLONIC NEOPLASMS; HUMANS; HYALURONIC ACID; LYMPHATIC METASTASIS; TUMOR CELLS, CULTURED; VIDEO RECORDING;

EID: 0032508704     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00201-8     Document Type: Conference Paper

References (36)

1. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
2. Bertrand P., Girard N., Delpech B., Duval C., d'Anjou J., Dauce J.P. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int. J. Cancer. 52:1992;1-6.
3. Byers H.R., Etoh T., Doherty J.R., Sober A.J., Mihm M.C. Jr. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Am. J. Pathol. 139:1991;423-435.
4. Comper W.D., Laurent T.C. Physiological function of connective tissue polysaccharides. Physiol. Rev. 58:1978;255-315.
5. Culty M., Miyake K., Kincade P.W., Silorski E., Butcher E.C., Underhill C. The hyaluronate receptor is a member of the CD44(H-CAM) family of cell surface glycoproteins. J. Cell Biol. 111:1990;2765-2774.
6. de la Torre M., Wells A.F., Bergh J., Lindgren A. Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum. Pathol. 24:1993;1294-1297.
7. de los Toyos J., Jalkanen S., Butcher E.C. Flow cytometric analysis of the Hermes homing-associated antigen on human lymphocyte subsets. Blood. 74:1989;751-760.
8. Friedl P., Noble P.B., Zänker K.S. Lymphocyte locomotion in three-dimensional collagen gels. Comparison of three quantitative methods for analysing cell trajectories. J. Immunol. Methods. 165:1993;157-165.
9. Friedl P., Maaser K., Klein C.E., Niggemann B., Krohne G., Zänker K.S. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of α2 and β1 integrins and CD44. Cancer Res. 57:1997;2061-2070.
10. Gagos S., Hopwood V.L., Iliopoulos D., Kostakis A., Karayannakos P., Yatzides H., Skalkeas G.D., Pathak S. Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient. Anticancer Res. 15:1995;369-378.
11. Grimmond H.E., Hill G.J., Zirvi K.A. Proteins excreted by primary human colon carcinoma cells (SW480) promote spreading and growth of metastatic human colon carcinoma cells (SW620) in serum-free medium. Cancer Biochem. Biophys. 10:1989;353-364.
12. Guirguis R., Margulies I., Taraboletti G., Schiffmann E., Liotta L. Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration. Nature. 329:1987;261-263.
13. Guo Y., Ma J., Wang J., Che X., Narula J., Bigby M., Wu M., Sy M.-S. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1994;1561-1565.
14. He Q., Lesley J., Hyman R., Ishihara K., Kincade P.W. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol. 119:1992;1711-1719.
15. Hofmann M., Rudy W., Zoeller M., Toelg C., Ponta H., Herrlich P., Guenthert U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 51:1991;5292-5297.
16. Hosaka S., Suzuki M., Goto M., Sato H. Motility of rat ascites hepatoma cells, with reference to malignant characteristics in cancer metastasis. Gann. 69:1978;273-276.
17. Kallioniemi A., Kallioniemi O.-P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
18. Knudson W., Biswas C., Toole B.P. Interactions between human tumor cells and fibroblasts stimulate hyaluronic acid synthesis. Proc. Natl. Acad. Sci. USA. 81:1984;6767-6771.
19. W. Knudson, C. Biswas, X.-Q. Li, R.E. Nemec, B.P. Toole, The role and regulation of tumor-associated hyaluronan, in: J. Whelan (Ed.), The Biology of Hyaluronan, Ciba Foundation Symposium, Wiley, Chichester, NY, 1989, pp. 150-169.
20. Kubens B.S., Nikolai G., Zänker K.S. Influence of hyaluronic acid or phorbol 12-myristate 13-acetate on the migration capacity of a murine lymphoma cell line (Eb) and its metastatic variant (ESb). Cancer Lett. 118:1997;189-200.
21. Laferté S., Prokopishyn N.L., Moyana T., Bird R.P. Monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane-induced rat colon tumors and human colon cancer cell lines. J. Cell. Biochem. 57:1995;101-119.
22. Leibovitz A., Stinson J.C., McCombs III W.B., McCoy C.E., Mazur K.C., Mabry N.D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36:1976;4562-4569.
23. Lesley J., Schulte R., Hyman R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 187:1990;224-233.
24. Lokeshwar V.B., Lokeshwar B.L., Pham H.T., Block N.L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 56:1996;651-657.
25. Lü H.Q., Niggemann B., Zänker K.S. Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules. J. Cancer Res. Clin. Oncol. 122:1996;335-342.
26. Miyake K., Underhill C.B., Lesley J., Kincade P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:1990;69-75.
27. Mohler J.L., Partin A.W., Coffey D.S. Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma model. J. Urol. 138:1987;168-170.
28. Muirhead K.A., Wallace P.K., Schmitt T.C., Frescatore R.L., Franco J.A., Horan P.K. Methodological considerations for implementation of lymphocyte subset analysis in a clinical reference laboratory. Ann. N. Y. Acad. Sci. 68:1986;113-127.
29. Pauli B.U., Knudson W. Tumor invasion: a consequence of destructive and compositional matrix alterations. Hum. Pathol. 19:1988;628-639.
30. Pham H.T., Block N.L., Lokeshwar V.B. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res. 57:1997;778-783.
31. Raz A., Ben-Ze'ev A. Cell-contact and -architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev. 6:1987;3-21.
32. Shah V., Kumar S., Zirvi K.A. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase. In vivo. 8:1994;321-326.
33. Stamenkovic I., Aruffo A., Amiot M., Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10:1991;343-348.
34. Thomas L., Byers H.R., Vink J., Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:1992;971-977.
35. Turley E.A., Austen L., Vandeligt K., Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. 112:1991;1041-1047.
36. Turley E.A. Hyaluronan and cell locomotion. Cancer Metastasis Rev. 11:1992;21-30.